오하이오의 궤양성 대장염 임상 시험
궤양성 대장염 관련 연구 24개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.
오하이오의 도시
공식 연구 텍스트(영어)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-025, Brunswick
- Site US-023, Dayton
- Site US-027, Westlake
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07845487Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03816345LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Ohio State University, Hilliard
- DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro, Springboro
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07415044Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Dayton Gastroenterology, LLC, Dayton
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07186101A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중3상
3세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06663332A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Great Lakes Gastroenterology Research, LLC, Mentor
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07577856ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- Gastro Intestinal Research Institute of Northern Ohio,, Westlake
피험자 모집 중관찰 연구건강한 지원자 환영
22세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06810518Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Beavercreek
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 75세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Cincinnati, Cincinnati
- DSI Research Northridge LLC, Dayton
- Gastro Health Research - Liberty Township, Liberty Township
- 외 3개
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Dayton Gastroenterology - Beavercreek /ID# 284065, Beavercreek
- Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University Hospitals Cleveland Medical Center Rainbow Babies & Children's Hospital, Cleveland
- University Hospitals Cleveland Medical Center, Cleveland
피험자 모집 중2상
12세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05287126A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University Hospitals Cleveland Medical Center /ID# 271831, Cleveland
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of Cincinnati College of Medicine, Cincinnati
- Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake
피험자 모집 중관찰 연구
18세 ~ 64세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology & Hepatology Specialists, Inc. - Site Number: 8400139, Canton
- Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
- OSU Wexner Medical Center - Site Number: 8400077, Columbus
- 외 4개
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07184996A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Cleveland Clinic, Cleveland
피험자 모집 중2/3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Ohio Gastroenterology Group Inc. - Site Number: 8400006, Columbus
- North Shore Gastroenterology Research - Site Number: 8400130, Westlake
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT07185009Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of Cincinnati, Cincinnati
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06750731A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Children's Clinic, Cleveland
- Cleveland Clinic, Cleveland
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06405087Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Cleveland Clinic Foundation, Cleveland
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT07513181Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Cincinnati, Cincinnati
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07237516A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
피험자 모집 중3상
2세 이상 · 모든 성별 · 2026. 5. 7. 업데이트됨 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Cincinnati
- Mirador Therapeutics Selected Site, Liberty Township
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522Evaluation of the SMART IBD App in Pediatric IBD
- Cincinnati Children's Hospital Medical Center, Cincinnati
피험자 모집 중
13세 ~ 17세 · 모든 성별 · 2025. 11. 21. 업데이트됨 · NCT07195123ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.